These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 22845410

  • 1. Current and emerging treatments in the management of castration-resistant prostate cancer.
    Shapiro D, Tareen B.
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):951-64. PubMed ID: 22845410
    [Abstract] [Full Text] [Related]

  • 2. New developments in castrate-resistant prostate cancer.
    Shore N, Mason M, de Reijke TM.
    BJU Int; 2012 Jun; 109 Suppl 6():22-32. PubMed ID: 22672122
    [Abstract] [Full Text] [Related]

  • 3. Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
    Lee DJ, Cha EK, Dubin JM, Beltran H, Chromecki TF, Fajkovic H, Scherr DS, Tagawa ST, Shariat SF.
    BJU Int; 2012 Apr; 109(7):968-85. PubMed ID: 22035221
    [Abstract] [Full Text] [Related]

  • 4. Recent advances in second-line treatment of castration-resistant prostate cancer.
    Ong M, Winquist E.
    Curr Opin Support Palliat Care; 2011 Sep; 5(3):199-205. PubMed ID: 21734586
    [Abstract] [Full Text] [Related]

  • 5. New and emerging agents for the treatment of castration-resistant prostate cancer.
    Higano CS, Crawford ED.
    Urol Oncol; 2011 Sep; 29(6 Suppl):S1-8. PubMed ID: 22074657
    [Abstract] [Full Text] [Related]

  • 6. New therapies for castration-resistant prostate cancer: efficacy and safety.
    Beltran H, Beer TM, Carducci MA, de Bono J, Gleave M, Hussain M, Kelly WK, Saad F, Sternberg C, Tagawa ST, Tannock IF.
    Eur Urol; 2011 Aug; 60(2):279-90. PubMed ID: 21592649
    [Abstract] [Full Text] [Related]

  • 7. Clinical roundtable monograph: new and emerging treatments for advanced prostate cancer.
    George DJ, Kantoff PW, Lin DW.
    Clin Adv Hematol Oncol; 2011 Jun; 9(6):1-11; discussion 11-5. PubMed ID: 21941983
    [Abstract] [Full Text] [Related]

  • 8. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer].
    Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, van der Kwast T, Wiegel T, Zattoni F, Heidenreich A.
    Actas Urol Esp; 2011 Jun; 35(10):565-79. PubMed ID: 21757258
    [Abstract] [Full Text] [Related]

  • 9. New and emerging treatments for advanced prostate cancer.
    George DJ, Kantoff PW, Lin DW.
    Clin Adv Hematol Oncol; 2011 Jun; 9(6 Suppl 12):1-15. PubMed ID: 22361744
    [Abstract] [Full Text] [Related]

  • 10. Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: the Australian perspective.
    Parente P, Parnis F, Gurney H.
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):31-42. PubMed ID: 22369442
    [Abstract] [Full Text] [Related]

  • 11. Castration-resistant prostate cancer: many treatments, many options, many challenges ahead.
    Garcia JA, Rini BI.
    Cancer; 2012 May 15; 118(10):2583-93. PubMed ID: 22038761
    [Abstract] [Full Text] [Related]

  • 12. Novel agents for the management of castration-resistant prostate cancer.
    Haddad H, Garcia JA.
    Curr Opin Urol; 2012 May 15; 22(3):175-82. PubMed ID: 22472509
    [Abstract] [Full Text] [Related]

  • 13. [The treatment of castration-resistant prostate cancer].
    Petrányi Á.
    Magy Onkol; 2012 Dec 15; 56(4):219-28. PubMed ID: 23236591
    [Abstract] [Full Text] [Related]

  • 14. Castration-refractory prostate cancer: New drugs in the pipeline.
    Schrijvers D, Van Erps P, Cortvriend J.
    Adv Ther; 2010 May 15; 27(5):285-96. PubMed ID: 20532721
    [Abstract] [Full Text] [Related]

  • 15. Emerging treatment options for patients with castration-resistant prostate cancer.
    George D, Moul JW.
    Prostate; 2012 Feb 15; 72(3):338-49. PubMed ID: 21748753
    [Abstract] [Full Text] [Related]

  • 16. New therapeutic strategies for castration-resistant prostate cancer.
    Tanaka T, Nakatani T.
    Recent Pat Anticancer Drug Discov; 2011 Sep 15; 6(3):373-83. PubMed ID: 21612574
    [Abstract] [Full Text] [Related]

  • 17. Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer.
    Clarke NW.
    BJU Int; 2012 Oct 15; 110 Suppl 1():14-22. PubMed ID: 23046036
    [Abstract] [Full Text] [Related]

  • 18. Update on castrate-resistant prostate cancer: 2010.
    Lassi K, Dawson NA.
    Curr Opin Oncol; 2010 May 15; 22(3):263-7. PubMed ID: 20177381
    [Abstract] [Full Text] [Related]

  • 19. Novel strategies in the treatment of castration-resistant prostate cancer (Review).
    Marech I, Vacca A, Ranieri G, Gnoni A, Dammacco F.
    Int J Oncol; 2012 May 15; 40(5):1313-20. PubMed ID: 22322981
    [Abstract] [Full Text] [Related]

  • 20. Abiraterone acetate in castration-resistant prostate cancer.
    Iacovelli R, Palazzo A, Procopio G, Gazzaniga P, Cortesi E.
    Anticancer Drugs; 2012 Mar 15; 23(3):247-54. PubMed ID: 22123334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.